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Notch signaling in T cells is essential for allergic
airway inflammation, but expression of the Notch
ligands Jagged 1 and Jagged 2 on dendritic cells is
dispensableIrma Tindemans, MSc,a Melanie Lukkes, BSc,a Marjolein J. W. de Bruijn, BSc,a Bobby W. S. Li, MSc,a
Menno van Nimwegen, BSc,a Derk Amsen, PhD,b Alex KleinJan, PhD,a* and Rudi W. Hendriks, PhDa* Rotterdam and
Amsterdam, The NetherlandsBackground: Allergic asthma is characterized by a TH2
response induced by dendritic cells (DCs) that present inhaled
allergen. Although the mechanisms by which they instruct TH2
differentiation are still poorly understood, expression of the
Notch ligand Jagged on DCs has been implicated in this process.
Objective: We sought to establish whether Notch signaling
induced by DCs is critical for house dust mite (HDM)–driven
allergic airway inflammation (AAI) in vivo.
Methods: The induction of Notch ligand expression on DC
subsets by HDM was quantified by using quantitative real-time
PCR. We used an HDM-driven asthma mouse model to compare
the capacity of Jagged 1 and Jagged 2 single- and
double-deficient DCs to induce AAI. In addition, we studied AAI
in mice with a T cell–specific deletion of recombination
signal–binding protein for immunoglobulin Jk region (RBPJk),
a downstream effector of Notch signaling.
Results: HDM exposure promoted expression of Jagged 1, but
not Jagged 2, on DCs. In agreement with published findings,
in vitro–differentiated and HDM-pulsed Jagged 1 and Jagged 2
double-deficient DCs lacked the capacity to induce AAI.
However, after in vivo intranasal sensitization and challenge
with HDM, DC-specific Jagged 1 or Jagged 2 single- or
double-deficient mice had eosinophilic airway inflammation and
a TH2 cell activation phenotype that was not different from that
in control littermates. In contrast, RBPJk-deficient mice did not
experience AAI and airway hyperreactivity.
Conclusion: Our results show that the Notch signaling pathway
in T cells is crucial for the induction of TH2-mediated AAI in an
HDM-driven asthma model but that expression of Jagged 1 or
Jagged 2 on DCs is not required. (J Allergy Clin Immunol
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Allergic asthma is a TH2 cell–mediated disease characterized by
chronic airway inflammation, airway hyperreactivity, and episodes
of bronchoconstriction. Inflammatory dendritic cells (DCs) are
necessary for induction of TH2 immunity to inhaled house dust
mite (HDM) allergen in mice, as was shown in CD11c–diphtheria
toxin receptor mice in which DCs were specifically depleted by
diphtheria toxin exposure.1 Lung-resident DCs continuously
sample the airway lumen for the presence of allergens, such as
HDM, and once activated, these cells mature and migrate to the
draining lymph nodes to activate naive T cells.2 On antigenic
stimulation by DCs, TH2 cell differentiation is initiated whereby
the polarizing cytokine IL-4, which induces phosphorylation and
activation of signal transducer and activator of transcription 6,
enhances expression of the key TH2 transcriptional regulator
Gata-3.3 TH2 cells are potent producers of cytokines that induce
IgE synthesis (IL-4), recruit eosinophils (IL-5), and cause smooth
muscle hyperreactivity and goblet cell hyperplasia (IL-13).
Therefore initiation of TH2 cell differentiation through the
IL-4/signal transducer and activator of transcription 6 axis is
suggestive of an autocrine loop that leads to expansion of IL-4–
producing T cells. However, the primary origin of IL-4, which
induces the TH2 response, remains unclear.
One of the pathways that has been implicated in the initiation of
TH2 cell differentiation is the Notch signaling pathway. It has been
demonstrated that Notch signaling has the capacity to induce TH2
cell differentiation by (1) directly activating the upstream Gata3
gene promoter and (2) regulating Il4 gene transcription through
activation of a 39 enhancer.4-6 Both of these are dependent on a nu-
clear complex that includes recombination signal–binding protein
for the immunoglobulin Jk (RBPJk) region and the coactivator
mastermind-like 1 (MAML1). Notch signaling in CD41 T cells
is required for physiologic TH2 responses to parasite antigens, as
was shown in mice deficient for the RBPJk region or the Notch 1
and Notch 2 receptors4 and in mice expressing dominant negative
MAML.7 Moreover, pharmacologic inhibition of g-secretase, the
enzyme that liberates the intracellular Notch domain from the
plasma membrane, allowing it to function as a transcription factor
in the nucleus, led to decreased TH2 cytokine production after im-
munization with ovalbumin (OVA) in an asthma model.8
Several lines of research support that the Notch ligands
Delta-like ligand (DLL) and Jagged instruct TH1 and TH2 cell
differentiation, respectively.9 Surface DLL expression was shown
to promote TH1 cell generation and to reduce TH2 responses,1
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TH2 effector generation.
6 Jagged 1 can be upregulated on DCs by
stimuli that promote TH2 cell responses, such as through thymic
stromal lymphopoietin, which is produced by diesel exhaust par-
ticle–treated human bronchial epithelial cells,10 and on stimula-
tion with Trypanosoma brucei–derived antigens, as well as
TNF, Dermatophagoides pteronyssinus group 7 allergen (Der p
7), and low-dose LPS.11-13 Jagged 1 was shown to be crucial in
the induction of a TH2 response in a model of airway hyperres-
ponsiveness using OVA-pulsed, in vitro–cultured, GM-CSF
bone marrow–derived dendritic cells (BMDCs).14 Although evi-
dence was provided that Jagged 2 is dispensable for the induction
of TH2 cells in vivo,
15,16 Jagged 2 was shown to have the capacity
to induce TH2 cell differentiation in vitro.
15 Correspondingly,
DLL1 and DLL4 ligands are induced on DCs by stimuli that elicit
TH1 responses and have the capacity to induce TH1 differentiation
in vitro.17,18
In contrast to this model, it has been hypothesized that Notch
signaling acts as a general amplifier of helper T-cell responses
rather than an instructive director of specific cell fates. This could
be through either enhancing proliferation, cytokine production,
and antiapoptotic signals19-21 or boosting antigen sensitivity
through promotion of costimulatory signals in T cells.22,23
Therefore in this report we aimed to determine whether Notch
signaling is critical for HDM-driven allergic airway inflammation
(AAI) in vivo. In particular, we questioned whether Jagged 1 and
Jagged 2 on DCs are required for the induction of polarization of
naive T cells into TH2 cells. We found that expression of Jagged 1
or Jagged 2 on DCs is not required, whereas T cells do need Notch
signals, specifically to differentiate into TH2 cells.
METHODS
For detailed methods, including mice used, experimental protocols and
statistical analysis, see the Methods section in this article’s Online Repository
at www.jacionline.org.RESULTS
Jagged 1 is upregulated on in vitro GM-CSF BMDCs
on exposure to HDM
Because several research groups have shown a role for Jagged
in the orchestration of T-cell responses by using GM-CSFBMDCs,6,11,14-16 we first investigated the expression of Notch
ligands on BMDCs on stimulation with the pro-TH2
stimulus HDM and the pro-TH1 stimulus LPS. GM-CSF BMDCs
were cultured from wild-type (WT) mice and sorted at day 9 into
CD11c1MHC class IIintF4/802CD1151 GM–monocyte-derived
dendritic cells (MoDCs), CD11c1MHCIIhighF4/802CD1152
GM-DCs, and CD11c1MHCIIintF4/801CD1151 GM-macro-
phages (Fig 1, A) based on the study by Helft et al.24 On
HDM stimulation, Jag1 mRNA was upregulated on
GM-MoDCs and GM-DCs, whereas LPS stimulation induced
upregulation of DLL4 mRNA on GM-MoDCs and GM-
macrophages. Expression of Jag2 and DLL1 was not altered on
GM-CSF BMDCs on stimulation (Fig 1, A). Thus Jag1 mRNA
is substantially upregulated on in vitro GM-CSF BMDCs after
HDM stimulation.Jagged is crucial during the sensitization phase in a
model that uses GM-CSF BMDCs to induce AAI
To delete Jag1 and Jag2 specifically in DCs, we used Jag1fl/fl
and Jag2fl/fl mice, in which the Jag loci contain loxP sites, as
well as CD11c-Cre transgenic mice, expressing Cre recombinase
under the control of the DC-specific CD11c promoter. Efficiency
of CD11c-Cre–mediated deletion was confirmed in CD11c-Cre
transgenic ROSAEYFP mice with Cre-mediated excision of a
loxP-flanked transcriptional STOP sequence. GM-CSF
BMDCs were cultured from CD11c-Cre3ROSAEYFP and
WT3ROSAEYFP mice with GM-CSF. Analysis of enhanced
yellow fluorescent protein (EYFP) expression by means of flow
cytometry indicated that GM-CSF BMDC subsets manifested
Cre-mediated deletion in 70% to 74% of the cells (see Fig E1, A,
in this article’s Online Repository at www.jacionline.org).
Next, we analyzed Jagged mRNA expression in DCs from
CD11c-Cre transgenic Jag1fl/flJag2fl/fl mice (Jg1Jg2DCD11c/DCD11c)
and Jg1Jg21/1 control mice (Fig 1, B). We found reduced
expression of Jag1 and Jag2 compared with that seen in WT
DCs in all GM-CSF BMDC subsets. Finally, recombination
of Jag1 and Jag2 was confirmed on genomic DNA of GM-
CSF BMDCs from Jg1Jg2DCD11c/DCD11c mice compared with
Jg1Jg21/1 mice (see Fig E1, B).
To confirm that Jagged expression on DCs is essential for AAI
induction by means of intratracheal transfer of allergen-pulsed
GM-CSF BMDCs, we sensitized WT mice with HDM-pulsed
total GM-CSF BMDCs from Jg1Jg2DCD11c/DCD11c or Jg1Jg21/1
mice and challenged the mice with HDM (Fig 2, A).
HDM-stimulated Jg1Jg21/1 GM-CSF BMDCs induced AAI, as
evidenced by a significant increase in numbers of eosinophils,
macrophages, neutrophils, B cells, T cells, and DCs in
bronchoalveolar lavage (BAL) fluid compared with numbers in
mice sensitized with PBS-treated GM-CSF BMDCs (Fig 2, B).
In contrast, GM-CSF BMDCs from Jg1Jg2DCD11c/DCD11c mice
lacked the capacity to induce AAI (Fig 2, B). Accordingly,
numbers of IL-41, IL-51, IL-131, IFN-g1, and IL-17A1T cells
in BAL fluid (Fig 2,C) or Gata-31TH2 cells in mediastinal lymph
nodes (MedLNs; Fig 2, D and E) were reduced when mice were
sensitized with Jg1Jg2DCD11c/DCD11c GM-CSF BMDCs
compared with control DCs. Numbers of Rorgt1 TH17 cells or
Foxp31 regulatory T cells in MedLNs were not different between
the 2 groups of mice, and T box–containing protein expression
was not detected (data not shown).
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FIG 1. Jagged 1 is upregulated on BMDCs on HDM exposure, and CD11c-Cre is effective in GM-CSF BMDCs.
A, Flow cytometric gating strategy for BMDC subsets from C57BL/6 mice. Live cells were analyzed for CD11c
and MHC class II and gated as indicated (top). mRNA expression of the indicated Notch ligands quantified
by using quantitative real-time PCR (qRT-PCR) in GM-MoDCs, GM-DCs, and GM-macrophages and
stimulated overnight in the presence or absence of HDM or LPS, as indicated (bottom). B, Quantification
of relative Jagged 1 and Jagged 2 expression by using qRT-PCR in BMDC subsets that were
fluorescence-activated cell sorted from Jg1Jg2DCD11c/DCD11c mice compared with WT C57BL/6 mice, which
were set to 100%. Data are shown as means 1 SEMs of 4 mice per group in 1 experiment, except for
HDM-stimulated GM-DCs (n 5 2 in Fig 1, A, and n 5 1 in Fig 1, B). *P < .05, Mann-Whitney U test.
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TINDEMANS ET AL 3The defective capacity of Jg1Jg2DCD11c/DCD11c GM-CSF
BMDCs (see Fig E2, A, in this article’s Online Repository at
www.jacionline.org) to induce TH2 polarization in vivowas likely
not due to cell-intrinsic defects because these DCs expressed
similar levels of costimulatory molecules (see Fig E2, B),
DLL1, and DLL4 (see Fig E2, C) and produced similar amountsof proinflammatory cytokines (see Fig E2,D), as did control DCs
on in vitro activation with a variety of stimuli.
Finally, to investigatewhether expression of Jagged 1 and Jagged
2 is perhaps also required during the challenge phase of AAI
induction, Jg1Jg2DCD11c/DCD11c or Jg1Jg21/1micewere sensitized
with WT GM-CSF BMDCs and challenged with HDM. We found
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FIG 2. Jagged 1 and Jagged 2 are crucial during the sensitization phase when using GM-CSF BMDCs
to induce AAI. A, Sensitization and challenge scheme of HDM-driven AAI in mice using cultured total
BMDCs. B, Numbers of macrophages (FSChighSSChighAutofluorescent1CD11c1Siglec-F1), eosinophils
(FSCintSSChighSiglec-F1), neutrophils (Ly-6G1), B cells (CD191), T cells (CD31), and DCs (CD11c1MHC class
IIhi) in BAL fluid in mice treated with either PBS-pulsed or HDM-pulsed BMDCs from Jg1Jg2DCD11c/DCD11c or
Jg1Jg21/1 mice. FSC, Forward scatter; SSC, side scatter. C, Numbers of IL-41, IL-51, IL-131, IFN-g1, and
IL-17A1 CD31CD41 T cells in BAL fluid in mice treated with either PBS-pulsed or HDM-pulsed BMDCs.
D, Flow cytometric profile of Gata-3/Rorgt expression in CD31CD41 T cells in mice treated with
HDM-pulsed BMDCs from Jg1Jg2DCD11c/DCD11c or Jg1Jg21/1 mice. E, Total numbers of Gata-31, Rorgt1,
and Foxp31CD251 CD31CD41 T cells in MedLNs from mice treated with PBS- or HDM-pulsed BMDCs
from Jg1Jg2DCD11c/DCD11c or Jg1Jg21/1 mice, as indicated. Data are shown as means 1 SEMs of 4 (PBS)
or 6 (HDM) mice per group in 1 experiment. *P < .05 and **P < .01, Mann-Whitney U test.
J ALLERGY CLIN IMMUNOL
nnn 2017
4 TINDEMANS ET ALcomparable AAI induction in Jg1Jg2DCD11c/DCD11c and Jg1Jg21/1
mice (not shown), indicating that for AAI induction, Jagged
expression is only required on GM-CSF BMDCs during the
sensitization phase and not during HDM challenge.
Taken together, these findings confirm that expression of
Jagged 1 and Jagged 2 is crucial during the sensitization phase
in a model in which GM-CSF BMDCs are used to induce
HDM-driven AAI.Jagged 1 is highly upregulated on in vivomigratory
CD11b1 conventional DCs on HDM exposure
To analyze the role of Jagged expression in a more physiologic
HDM-driven airway inflammation model, we first aimed to
establish which in vivo DC subsets express crucial Notch ligands
during HDM exposure. In this context CD11b1 conventional
dendritic cells (cDCs) were shown to be the main DC subset
involved in induction of TH2 cells in the draining lymph nodes,
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FIG 3. Jagged 1 is upregulated on migratory CD11b1 cDCs on HDM exposure, and CD11c-Cre is effective in
in vivo DCs. A, Gating strategy of ex vivo–sorted DC subsets from C57BL/6 mice intranasally treated with
50 mg of HDM or PBS (top). mRNA expression of the indicated Notch ligands, as determined by using
qRT-PCR, in DAPI2MHC class IIhiCD11b1CD1032CD642 (migratory) DCs from MedLNs after 72 hours of
in vivo stimulation (bottom). Six mice were pooled per sample. Data are shown as means 1 SEMs of 3
samples per group in 1 experiment. B, EYFP expression in CD11c1MHC class IIhi DCs in the indicated tissues
fromWT3ROSAEYFP and CD11c-Cre3ROSAEYFPmice after 72 hours of in vivo stimulation with 50 mg of HDM
or PBS. Data are shown as histogram overlays of EYFP expression in the indicated mice. Samples were
concatenated, and data are shown as means 1 SDs of 4 mice (CD11c-Cre3ROSAEYFP) or 2 to 3 mice
(WT3ROSAEYFP) per group in 1 experiment.
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TINDEMANS ET AL 5whereas MoDCs play a crucial role during the challenge phase.25
We sorted resident MoDCs, migratory MoDCs, resident CD11b1
cDCs, and migratory CD11b1 cDCs from MedLNs of WT mice
intranasally treated with HDM or PBS for 72 hours. In migratory
CD11b1 cDCs, both Jagged 1 and DLL4 were expressed at
baseline and significantly upregulated on exposure to HDM,
whereas Jagged 2 and DLL1 were not detected (Fig 3, A).
Resident MoDCs, migratory MoDCs, and resident CD11b1
cDCs expressed very low levels of Jag1 mRNA, and expression
of other Notch ligands was not detected (data not shown).Jag1 and Jag2 are effectively deleted in DCs from
Jg1Jg2DCD11c/DCD11c mice
To check the efficacy of CD11c-Cre–mediated in vivo gene
deletion, we analyzed DCs from CD11c-Cre3ROSAEYFP and
control mice. EYFP was expressed in 88% to 97% of
CD11c1MHC class IIhigh DCs in lungs, BAL fluid, MedLNs,
and spleens and was unaltered when mice were challenged with50 mg of HDM 72 hours before analysis (Fig 3, B, and see
Table E2 in this article’s Online Repository at www.jacionline.
org for a detailed analysis of EYFP expression in DC subsets
and other immune cells). In accordance with the EYFP data,
Jag1 and Jag2 mRNA expression was not detected in migratory
CD11b1 cDCs sorted from MLNs from Jg1Jg2DCD11c/DCD11c
mice (data not shown).
Together, these data show that Jagged 1, but not Jagged 2, is
substantially upregulated on migratory CD11b1 cDCs on stimula-
tion with HDM. In addition, DCs from Jg1Jg2DCD11c/DCD11c mice
showalmost complete invivodeletion of both Jagged1 and Jagged2.Mice lacking Jagged expression on DCs have AAI
similar to that seen in WT animals
Next, we used an acute AAI model by sensitizing and
challenging Jg1Jg2DCD11c/DCD11c and Jg1Jg21/1 mice with
HDM. Four days after the last challenge, mice were analyzed
(Fig 4, A). Surprisingly, after HDM exposure, both
A
0 7 8 9 10 11 15Day:
Sensitisation with
1 μg HDM or PBS 
Challenges with 
10 μg HDM x5
Analysis
B
Jg1Jg2
Jg1Jg2
C D
F
E
G
Macrophages
0
1∙10
2∙10
3∙10
PBS HDM
C
el
l c
ou
nt
s
in
B
A
L
Eosinophils
0
2∙10
4∙10
PBS HDM
Neutrophils B cells
0
2∙10
4∙10
6∙10
PBS HDM
T cells
0
2∙10
4∙10
PBS HDM
DCs
0
0.5∙10
1.0∙10
1.5∙10
PBS HDM
0.28 0.02
99 0.55
5.0 4.5
83 7.4
0.28 0
100 0.12
0.44 0.04
99 0.56
5.9 4.7
84 5.8
0.24 0
100 0.11
Jg1Jg2 Jg1Jg2
IL
-4
IFN-γ
IL
-5
IL-13
IL
-9
IL-17A
IL-5
0
1∙10
2∙10
pg
/m
l
Gata3
0
4∙10
8∙10
**
PBS HDM
C
el
l c
ou
nt
s
in
B
A
L
Rorγt
0
0.5∙10
1.0∙10
1.5∙10
PBS HDM
Foxp3 CD25
0
1∙10
2∙10
PBS HDM
Total IgE
0
4∙10
8∙10
*
Ig
E
(n
g/
m
l)
PBS HDMPBS HDM
H
Jg1/Jg2
Jg1
Jg2
PBS HDM
IL-4
0
1∙10³
2∙10³
PBS HDM
IL-5
0
1∙10
2∙10
PBS HDM
IL-13
0
1∙10
2∙10
3∙10
PBS HDM
IL-9
0
1∙10³
PBS HDM
IL-17
0
1∙10
PBS HDM
IFN-γ
0
1∙10
PBS HDM
N
um
be
ro
fp
os
iti
ve
C
D
4
T
ce
lls
in
B
A
L
0
1∙10
2∙10
3∙10
PBS HDM
**
**
**
**
**
**
**
**
**
**
*
*
**
**
**
**
** **
**
*
**
**
**
**
**
** **
Eosinophils
0
1∙10
2∙10
3∙10
*
*
*
C
el
l c
ou
nt
s
i n
B
A
L
IL-5 CD4 T cells
0
2∙10³
4∙10³
6∙10³
*
PBS HDM
HDM specific IgE
0.0
0.5
1.0
1.5
O
D
HDM specific IgG1
0.0
0.4
0.8
PBS HDM PBS HDM
**
** **
**
FIG 4. Jagged 1 and Jagged 2 expression on DCs is dispensable for the development of AAI in vivo.
A, Scheme of HDM-mediated AAI induction in mice. B, Total numbers of indicated cell populations in
BAL fluid from PBS- or HDM-treated Jg1Jg2DCD11c/DCD11c or Jg1Jg21/1 mice. C and D, Intracellular flow
cytometric analysis of cytokine production by CD31CD41 T cells in BAL fluid from the indicated mice
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TINDEMANS ET AL 7Jg1Jg2DCD11c/DCD11c and Jg1Jg21/1 mice had similar AAI
inflammation characterized by increased numbers of
macrophages, eosinophils, neutrophils, B cells, and T cells in
BAL fluid compared with those in PBS-sensitized mice (Fig 4,
B). Jg1Jg2DCD11c/DCD11c and Jg1Jg21/1 mice showed similar
increases in IL-4–, IL-5–, IL-13–, and IL-9–expressing CD41
T cells, and numbers of IFN-g or IL-17A helper T cells were
similar (Fig 4, C and D). Accordingly, restimulated MedLN cells
from Jg1Jg2DCD11c/DCD11c and Jg1Jg21/1 mice showed no
difference in HDM-induced IL-5 production (Fig 4, E). In
addition, numbers of Gata-31 T cells were higher in
HDM-treated Jg1Jg2DCD11c/DCD11c mice compared with those
in Jg1Jg21/1 control mice. In these experiments the numbers
of Rorgt1 and Foxp31 T cells were not different between the 2
groups (Fig 4, F). T box–containing protein–positive T cells
were not detected (data not shown). Although total serum IgE
levels were higher in Jg1Jg2DCD11c/DCD11c mice compared
with those in Jg1Jg21/1mice, HDM-specific IgE and IgG1 levels
in serum were similar in the 2 HDM-treated mouse groups (Fig 4,
G). When we analyzed single-gene conditional knockouts, we
found, as expected, that Jg1DCD11c/DCD11c and Jg2DCD11c/DCD11c
mice had AAI similar to that seen in WT littermates on HDM
exposure (Fig 4, H).
To verify that DC migration and responsiveness were
comparable between Jg1Jg2DCD11c/DCD11c and Jg1Jg21/1 mice,
the DC response to HDM was analyzed 24 hours after intranasal
administration of either PBS, 10 mg of HDM, or 50 mg of HDM
(see Fig E3, A, in this article’s Online Repository at
www.jacionline.org). We did not detect differences in the
numbers of cells of individual DC subsets (see Fig E3, B and C)
or in the expression of costimulatory molecules on total DCs
(see Fig E3, D) or separate DC subsets (data not shown) in the
MedLNs or lungs between Jg1Jg2DCD11c/DCD11c and Jg1Jg21/1
mice. We noticed a small but significant increase in DLL4
expression on DCs in the MedLNs of Jg1Jg2DCD11c/DCD11c
compared with Jg1Jg21/1 mice.
Taken together, our analysis demonstrates that in the
HDM-driven asthma model there is no evidence for a role for
Jagged 1 or Jagged 2 expression on DCs.Conditional Jagged 1 and Jagged 2 knockout mice
have normal TH1 responses in vivo
Although TH2 responses still developed in the HDM model in
mice with Jagged-deficient DCs, it remained possible that these
mice had a shift in TH1/TH2 balance. However, when we analyzed
in vitro recall responses to OVA, there was no difference in T-cell
activation, TH1 cells, or TH2 cells (see Fig E4,A-D, in this article’s
Online Repository at www.jacionline.org) or IL-41 and IFN-g1
T cells (not shown) between in vitro OVA-restimulated lymph
node cells from Jg1Jg2DCD11c/DCD11c and Jg1Jg21/1 mice.
Likewise, no differences were found in T cell–dependent B-cell(Fig 4, C) and quantification of total numbers of cytokin
E, Quantification of IL-5 production in vitro by MedLN c
quantified by means of ELISA. F, Numbers of Gata-31,
fluid from PBS- or HDM-treated Jg1Jg2DCD11c/DCD11c o
HDM-specific IgE and IgG1 in serum of indicated mice
T cells in BAL fluid from PBS- or HDM-treated Jg1DCD11
shown as means 1 SEMs of 6 to 7 mice per group and
*P < .05 and **P < .01, Mann-Whitney U test.responses because total or high affinity tri-nitrophenol keyhole
limpet hemagglutinin–specific IgM, TH2-driven IgG1, and TH1-
driven IgG2c levels were similar in Jg1Jg2
DCD11c/DCD11c and
Jg1Jg21/1 mice (see Fig E4, F and G). Therefore the absence
of Jagged expression on DCs does not affect the TH1/TH2 balance
in vivo.Canonical Notch signaling through RBPJk in CD41
T cells is required for AAI development
Mice with T cell–specific conditional deletion of the down-
stream transcription factor RBPJk6 were studied to establish
whether Notch signaling in T cells is critical for induction of
TH2 differentiation. We exposed CD4-Cre transgenic RBPJk
fl/fl
mice (termed RBPJkDCD4/DCD4) and non–CD4-Cre–expressing
RBPJkfl/fl littermates (termed RBPJk1/1) to our HDM-driven
AAI model (Fig 5, A). Strikingly, in the absence of RBPJk in T
cells, mice displayed a significant decrease in numbers of macro-
phages, eosinophils, neutrophils, B cells, T cells, and DCs in BAL
fluid compared with WT littermates (Fig 5, B). Also, the numbers
and percentages of IL-41, IL-51, and IL-131 T cells were lower
in RBPJkDCD4/DCD4 than in RBPJk1/1 mice, whereas we found
similar numbers and increased percentages of IFN-g1 and
IL-17A1 T cells in BAL fluid, MedLNs, and lungs (Fig 5, C
and D, and data not shown). Moreover, the ratio of cytokine-
producing T cells shifted from a predominant TH2 phenotype to
a more equal TH1/TH2/TH17 phenotype in the absence of RBPJk
in T cells (Fig 5, E). In addition, induction of Gata-3 was
particularly impaired in RBPJkDCD4/DCD4 mice in CD41 cells
in BAL fluid, MedLNs, and lungs (Fig 5, F and G, and data not
shown), Furthermore, serum IgE levels (Fig 5, H) and airway
resistance to methacholine were significantly lower in
RBPJkDCD4/DCD4 mice compared with values in RBPJk1/1
mice (Fig 5, I).
In summary, these results demonstrate that canonical
RBPJk-mediated Notch signaling in CD41 T cells is crucial for
the induction of AAI and airway hyperreactivity in vivo.DISCUSSION
Notch signaling inTcells is crucial to induce aTH2 response.This
was shown earlier in mousemodels using parasite antigens4,7 and in
asthmamodels usingOVA.8 In linewith these reports, we found that
mice with T cell–specific RBPJk deficiency did not mount a TH2
response in an HDM-induced mouse AAI model. However, the
role of theNotch ligands Jagged 1 and Jagged 2 inTH2 induction re-
mainsmore elusive.Herewe show that onHDMexposure, Jagged 1
is specifically upregulated onmigratoryCD11b1 cDCs inMedLNs,
but expression of Jagged 1 and Jagged 2 on DCs is dispensable for
the induction of HDM-induced AAI in vivo.
Although we found a substantial increase of Jagged 1
expression on HDM stimulation both in vivo and in vitro, Jaggede-positive CD31CD41 T cells in BAL fluid (Fig 4, D).
ells restimulated with 15 mg/mL HDM for 7 days, as
Rorgt1, and Foxp31CD251 CD31CD41 T cells in BAL
r Jg1Jg21/1 mice. G, Total IgE levels and levels of
. H, Cell counts of eosinophils and IL-51CD31CD41
c and Jg2DCD11c mice with WT littermates. Data are
are representative of 3 independent experiments.
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TINDEMANS ET AL 92 expression was low and remained unaltered. In addition, Jagged
1 was shown to be crucial in the induction of a TH2 response in an
AAI model by using OVA-pulsed in vitro–cultured GM-CSF
BMDCs,14 whereas Jagged 2 is not required for TH2 induction
in vivo.15,16 Therefore we hypothesized that Jagged 1, but not Jag-
ged 2, would be critical in the induction of AAI in vivo. However,
in our physiologic model using HDM to sensitize and challenge
mice, we found that expression of Jagged 1 and Jagged 2 on
DCs was dispensable. Nevertheless, our data based on transfer
of in vitro HDM-activated GM-CSF BMDCs confirmed earlier
literature showing that Jagged-deficient GM-CSF BMDCs are
incapable of inducing AAI in vivo14 in an OVA-based model.
Thus the requirement for Jagged expression on GM-CSF BMDCs
for their capacity to induce AAI does not appear to be dependent
on the nature of the allergen (HDMorOVA) but is likely related to
the use of GM-CSF BMDCs to sensitize the mice. In particular, it
was recently shown that GM-CSF BMDCs comprise a
heterogeneous cell population, consisting of both cDC-like cells
and monocyte-derived macrophages.24 These findings indicate
that data obtained by using in vivo transfer of GM-CSF BMDCs
should be interpreted with care.
Although there is no doubt that Notch is required to induce
proper effector T-cell responses, it is currently under debate
whether Notch ligands have an instructive role in helper T-cell
differentiation or whether Notch signaling acts as an amplifier of
helper T-cell responses.9 The results obtained after instillation of
Jagged-deficient DCs would appear to support a general role for
Notch in promoting helper T-cell responses. In contrast, in
RBPJk-deficient mice treated with HDM, we clearly observed a
selective defect in TH2 cell responses, whereas numbers of TH1
and TH17 cells were similar to those in WT mice, arguing for a
role for Notch as a TH2-instructive signal. We speculate that
Notch can perform both roles, enhance general T-cell activation,
and function as a more specific promoter of TH2 responses,
depending on the repertoire of signals mobilized. Thus when
HDM-treated DCs are used to prime the response, the repertoire
of additional T cell–activating signals might be limited. In that
case T-cell activation would become more dependent on Notch
activation. When, on the other hand, HDM is inhaled, many cell
types (innate lymphocytes, epithelial cells, and tissue-resident
myeloid cells) will contribute to the generation of activating
signals that might override the requirement for Notch in T-cell
priming. In this latter scenario only the TH2-promoting function
of Notch would be critical.
It has previously been suggested that the Notch ligands DLL
and Jagged instruct TH1 and TH2 responses, respectively.
6
However, we found that mice with a conditional deletion for
Jagged 1 and Jagged 2 in DCs had TH2 responses to HDM to a
similar extent as their WT littermates. These findings indicateFIG 5. Notch signaling in CD41 T cells is crucial for
induction in RBPJkDCD4/DCD4 and RBPJk1/1 mice. B, T
BAL fluid from PBS- or HDM-treated mice. C-E, Intracell
by CD31CD41 T cells in BAL fluid from the indicated
cytokine-positive CD31CD41 T cells in BAL fluid (Fig
(Fig 5, E), as signified by the key cytokines IL-5, IFN-g,
cytometric profile of transcription factor expression
G, Quantification of Gata-31, Rorgt1, and Foxp31 CD4
BAL fluid. H, Total IgE levels in serum, as determined by
directly after administration of increasing doses of m
groups. Data are shown as means 1 SEMs of 4 to 6 m
6 independent experiments (Fig 5, B-H). *P < .05 and *either (1) a critical role for other Jagged-expressing cells,
implying an instructive role for Notch signaling, or (2)
redundancy between various Notch ligands (Jagged 1, Jagged 2,
DLL1, and DLL4) on DCs during induction of TH2 responses,
which would argue for a role for Notch as an unbiased amplifier.
One explanation for the induction of a TH2 response in the
absence of Jagged 1 and Jagged 2 on DCs could be that there is
a redundancy of other Jagged-expressing cells. It is not likely
that Jagged expression on alveolar macrophages is required for
TH2 priming. First, although macrophages can take up HDM,
they have been reported to lack the capacity to induce T-cell
proliferation.25 Second, our finding of greater than 94% EYFP
expression in alveolar macrophages from CD11c-
Cre3ROSAEYFP mice (see Fig E2, B) would indicate that these
cells are Jagged deficient in the Jg1Jg2DCD11c/DCD11c mice also.
Another candidate would be B cells, which have been implicated
in induction of TH2-mediated AAI.
26-28 Also, B cells are
important in the development and maintenance of follicular
helper T cells,29 which play an important role in AAI by secreting
IL-4 and IL-21.27,30-32 However, in fluorescence-activated
cell-sorted activated and nonactivated B cells from
HDM-treated and control mice, Jagged 1 was not detected, and
levels of Jagged 2 were very low (I. Tindemans, unpublished
findings), which is inconsistent with a role for Jagged expression
on B cells in TH2 cell induction.
On stimulationwith HDM,we found that DLL4 expressionwas
increased on migratory CD11b1 cDCs in vivo (Fig 1, B). In the
absence of Jagged 1 and Jagged 2 on DCs, DLL4 expression
was increased (see Fig E4, D), raising the possibility that DLL4
compensates for the absence of Jagged 1 and Jagged 2. DLL4
signaling was originally thought to be associated with TH1
response induction.6,18 Indeed, DLL4 is upregulated on DCs in
response to TH1 stimuli, including bacterial LPS, respiratory
syncytial virus (RSV), and dengue virus.18,33,34 However, later
studies showed that it is also induced by certain TH2 stimuli,
including cockroach allergen, low-dose LPS, and RSV-
mediated allergic asthma exacerbations.12,35,36 Furthermore, a
regulatory role for DLL4 was demonstrated in TH2 responses to
cockroach allergen36 and when DLL4-pretreated BMDCs
stimulated with OVA were adoptively transferred to induce
AAI.37 On the other hand, TH2 responses were decreased when
DLL4 was neutralized in vivo in a mouse model for
RSV-mediated allergic asthma exacerbations.35 Therefore it is
unclear whether DLL4 compensates for the absence of Jagged
molecules on DCs or whether DLL4 has a regulatory role in
this setting. Further studies targeting both Jagged 1 and DLL4
Notch ligands are required to resolve this question.
In summary, we showed that Notch signaling is crucial for
induction of HDM-mediated eosinophilia, TH2 responses, andAAI induction. A, Scheme of HDM-mediated AAI
otal numbers of the indicated cell populations in
ular flow cytometric analysis of cytokine production
mice (Fig 5, C), quantification of total numbers of
5, D), and distribution of TH1, TH2, and TH17 cells
and IL-17A in BAL fluid of indicated mice. F, Flow
in CD31CD41 T cells in mice treated with HDM.
1 T cells and CD49b1 CD41 natural killer T cells in
means of ELISA. I, Airway resistance, as measured
ethacholine by using flexiVent in indicated mouse
ice per group (Fig 5, B-I) and are representative of
*P < .01, Mann-Whitney U test.
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10 TINDEMANS ET ALairway hyperreactivity in vivo, indicating that Notch on T cells
could be a potential therapeutic target in patients with allergic
asthma. In addition, our data indicate that there is redundancy,
either between various Jagged-expressing cells or between
Jagged and DLL on DCs. Therefore further studies are required
to identify which cells and which ligands provide the Notch
signals that are essential for TH2 induction in patients with
allergic asthma.
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Clinical implications: The Notch signaling pathway in T cells is
critical for development of HDM-drivenAAI inmice, indicating
it could be a potential therapeutic target in asthmatic patients.REFERENCES
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